Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
Circassia Pharmaceuticals (NIOX) Share Price & Analysis
5 Followers
NIOX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range41.52p - 75.00p
Previous Close64.6p
Volume208.02K
Average Volume (3M)809.51K
Market Cap
£272.73M
Enterprise Value253.93M
Total Cash (Recent Filing)£19.90M
Total Debt (Recent Filing)£1.10M
Price to Earnings (P/E)27.8
Beta0.56
Next Earnings
Sep 25, 2024EPS EstimateN/A
Next Dividend Ex-Date
May 23, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding422,120,630
10 Day Avg. Volume1,407,061
30 Day Avg. Volume809,510
Standard Deviation0.19
R-Squared0.07
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)5.38
Price to Sales (P/S)288.77
Price to Cash Flow (P/CF)20.80
P/FCF Ratio21.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Circassia Pharmaceuticals News
PremiumCompany Announcements
Circassia Pharmaceuticals Announces AGM DateOptions Prices
Currently, No data available
---
Ownership Overview
3.06% Insiders
0.02% Mutual Funds
<0.01% Other Institutional Investors
96.93% Public Companies and
Individual Investors
NIOX FAQ
What was Circassia Pharmaceuticals PLC’s price range in the past 12 months?
Circassia Pharmaceuticals PLC lowest share price was 41.52p and its highest was 75.00p in the past 12 months.
What is Circassia Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Circassia Pharmaceuticals PLC’s upcoming earnings report date?
Circassia Pharmaceuticals PLC’s upcoming earnings report date is Sep 25, 2024 which is in 152 days.
How were Circassia Pharmaceuticals PLC’s earnings last quarter?
Circassia Pharmaceuticals PLC released its earnings results on Mar 26, 2024. The company reported 0.017p earnings per share for the quarter, beating the consensus estimate of N/A by 0.017p.
Is Circassia Pharmaceuticals PLC overvalued?
According to Wall Street analysts Circassia Pharmaceuticals PLC’s price is currently Overvalued.
Does Circassia Pharmaceuticals PLC pay dividends?
Circassia Pharmaceuticals PLC pays a Notavailable dividend of 1p which represents an annual dividend yield of N/A. See more information on Circassia Pharmaceuticals PLC dividends here
What is Circassia Pharmaceuticals PLC’s EPS estimate?
Circassia Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Circassia Pharmaceuticals PLC have?
Circassia Pharmaceuticals PLC has 422,746,700 shares outstanding.
What happened to Circassia Pharmaceuticals PLC’s price movement after its last earnings report?
Circassia Pharmaceuticals PLC reported an EPS of 0.017p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.926%.
Which hedge fund is a major shareholder of Circassia Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:NIOX
---
Circassia Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
52.13%
12-Months-Change
Fundamentals
Return on Equity
11.47%
Trailing 12-Months
Asset Growth
-7.11%
Trailing 12-Months
Company Description
Circassia Pharmaceuticals PLC
Circassia Group PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the US and also has a presence in EU, Asia Pacific and Rest of world.
---
Technical Analysis
---